Durability of Original Monovalent mRNA Vaccine Effectiveness Against COVID-19 Omicron–Associated Hospitalization Among Children and Adolescents in the US Between 2021 and 2023
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
MMWR. Morbidity and Mortality Weekly Report
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Durability of Original Monovalent mRNA Vaccine Effectiveness Against COVID-19 Omicron-Associated Hospitalization in Children and Adolescents - United States, 2021-2023
MMWR Morb. Mortal. Wkly. Rep. 2024 Apr 18;73(15)330-338, LD Zambrano, MM Newhams, RM Simeone, AB Payne, M Wu, AO Orzel-Lockwood, NB Halasa, JM Calixte, PS Pannaraj, K Mongkolrattanothai, JA Boom, LC Sahni, S Kamidani, K Chiotos, MA Cameron, AB Maddux, K Irby, JE Schuster, EH Mack, A Biggs, BM Coates, KN Michelson, KE Bline, RA Nofziger, H Crandall, CV Hobbs, SJ Gertz, SM Heidemann, TT Bradford, TC Walker, SP Schwartz, MA Staat, SS Bhumbra, JR Hume, M Kong, MS Stockwell, TJ Connors, ML Cullimore, HR Flori, ER Levy, NZ Cvijanovich, MS Zinter, M Maamari, C Bowens, DM Zerr, JA Guzman-Cottrill, I Gonzalez, AP Campbell, AG RandolphFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.